Mariana Pelicano de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariana Pelicano de Almeida has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Mike R. Dekker
Department of Developmental Biology, Erasmus MC, Rotterdam, The Netherlands
3 shared publications - Raymond A. Poot
Department of Developmental Biology, Erasmus MC, Rotterdam, The Netherlands
3 shared publications Lize Meert
Department of Developmental Biology, Erasmus MC, Rotterdam, The Netherlands
2 shared publications- Wilfred F. J. van Ijcken
Erasmus MC
2 shared publications - Alessandro Vitriolo
Human Technopole, Viale Rita Levi-Montalcini 1, 20157, Milan, Italy
1 shared publication - Anke Van Dijck
Family Medicine and Population Health (FAMPOP), Department of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Nature Communications
Large-scale identification of the regulatory potential of SNPs in human neural stem cells
GWAS have identified thousands of SNPs associated with different human phenotypes. Most SNPs are located in non-coding regions of the genome, where a small subset of causal SNPs is thought to contribute to risk by regulating transcription. However, identification of such causal variants remains challenging due to linkage disequilibrium, where blocks of SNPs are inherited together. Here, we perform a massively parallel reporter assay called SuRE in human neural stem cells to assess the transcriptional regulatory potential of 7.1 million SNPs. We identify 7,002 SNPs with regulatory potential (emVars) among the 484,057 SNPs with sufficiently high expression. These emVars are enriched in enhancers and often coincide with binding sites for transcription factors, such as ZBTB33, YY1, and ETS factors. We overlap SuRE data with eQTL data to pinpoint likely gene-regulatory variants. Additionally, combining SuRE data with GWAS for seven neuropsychiatric phenotypes identifies 187 emVars in risk loci containing 183,186 SNPs assessed by SuRE. In conclusion, our SuRE dataset provides a rich source to prioritize genetic variants that may be relevant for complex human phenotypes.
- 3 November 2026
- Published by Springer Nature in Nature Communications
Open AccessLarge-scale identification of the regulatory potential of SNPs in human neural stem cells
GWAS have identified thousands of SNPs associated with different human phenotypes. Most SNPs are located in non-coding regions of the genome, where a small subset of causal SNPs is thought to contribute to risk by regulating transcription. However, identification of such causal variants remains challenging due to linkage disequilibrium, where blocks of SNPs are inherited together. Here, we perform a massively parallel reporter assay called SuRE in human neural stem cells to assess the transcriptional regulatory potential of 7.1 million SNPs. We identify 7,002 SNPs with regulatory potential (emVars) among the 484,057 SNPs with sufficiently high expression. These emVars are enriched in enhancers and often coincide with binding sites for transcription factors, such as ZBTB33, YY1, and ETS factors. We overlap SuRE data with eQTL data to pinpoint likely gene-regulatory variants. Additionally, combining SuRE data with GWAS for seven neuropsychiatric phenotypes identifies 187 emVars in risk loci containing 183,186 SNPs assessed by SuRE. In conclusion, our SuRE dataset provides a rich source to prioritize genetic variants that may be relevant for complex human phenotypes.
- Open Access
Disruption of ADNP-KDM1A-GTF2I complex drives neural differentiation imbalance in Helsmoortel-Van der Aa syndrome
Mutations in ADNP (Activity-Dependent Neuroprotective Protein) are among the most frequent monogenic causes of autism spectrum disorder (ASD) and lead to Helsmoortel-Van der Aa syndrome (HVDAS). Yet how ADNP dysfunction leads to HVDAS is unclear. We employed patient-derived induced pluripotent stem cells, cortical organoids and ADNP KO human neural stem cells (hNSCs) to clarify the cellular and molecular mechanism of HVDAS onset. We purified an ADNP-KDM1A-GTF2I (AKG) protein complex from hNSCs and show that it targets transposable elements (TEs) to repress nearby gene transcription. Upon ADNP KO, KDM1A binding is lost at promoters targeted by AKG, pointing to ADNP as the anchoring subunit of the AKG complex. HVDAS cortical organoids show impaired progenitor proliferation and accelerated neuronal differentiation, coupled with a sustained upregulation of neurogenesis transcriptional programs, including key transcription factors normally repressed by AKG. This work suggests that the AKG complex acts as the relevant ADNP unit in the molecular onset of HVDAS.
Open AccessDisruption of ADNP-KDM1A-GTF2I complex drives neural differentiation imbalance in Helsmoortel-Van der Aa syndrome
Mutations in ADNP (Activity-Dependent Neuroprotective Protein) are among the most frequent monogenic causes of autism spectrum disorder (ASD) and lead to Helsmoortel-Van der Aa syndrome (HVDAS). Yet how ADNP dysfunction leads to HVDAS is unclear. We employed patient-derived induced pluripotent stem cells, cortical organoids and ADNP KO human neural stem cells (hNSCs) to clarify the cellular and molecular mechanism of HVDAS onset. We purified an ADNP-KDM1A-GTF2I (AKG) protein complex from hNSCs and show that it targets transposable elements (TEs) to repress nearby gene transcription. Upon ADNP KO, KDM1A binding is lost at promoters targeted by AKG, pointing to ADNP as the anchoring subunit of the AKG complex. HVDAS cortical organoids show impaired progenitor proliferation and accelerated neuronal differentiation, coupled with a sustained upregulation of neurogenesis transcriptional programs, including key transcription factors normally repressed by AKG. This work suggests that the AKG complex acts as the relevant ADNP unit in the molecular onset of HVDAS.
- Open Access
The Integrator complex prevents premature neuronal differentiation through global control of transcription elongation
Transcription pause-release constitutes a key step in the regulation of gene expression. Pathogenic variants in various pausing regulators have been identified in neurodevelopmental disorders, but how transcription pause-release regulates neural development remains largely unknown. Here we show that a patient-specific in-frame deletion in Integrator subunit 8 (INTS8) that prevents association of this subunit with the Integrator complex results in a global increase in nascent transcription and precocious expression of neuronal genes in progenitor cells. Consequently, differentiating neural progenitors fail to sustain a proliferating progenitor cell population during cortical neuronal network formation, resulting in network collapse. We show that attenuation of RNApol2 pause-release by targeted degradation of BRD4 can revert neuronal gene activation and prevent premature progenitor cell loss. Our data demonstrate that a fine-tuned balance between RNApol2 pausing and elongation is crucial for normal neuronal development and suggest transcription pause-release as a druggable target for neurological defects in developmental disorders.
Open AccessThe Integrator complex prevents premature neuronal differentiation through global control of transcription elongation
Transcription pause-release constitutes a key step in the regulation of gene expression. Pathogenic variants in various pausing regulators have been identified in neurodevelopmental disorders, but how transcription pause-release regulates neural development remains largely unknown. Here we show that a patient-specific in-frame deletion in Integrator subunit 8 (INTS8) that prevents association of this subunit with the Integrator complex results in a global increase in nascent transcription and precocious expression of neuronal genes in progenitor cells. Consequently, differentiating neural progenitors fail to sustain a proliferating progenitor cell population during cortical neuronal network formation, resulting in network collapse. We show that attenuation of RNApol2 pause-release by targeted degradation of BRD4 can revert neuronal gene activation and prevent premature progenitor cell loss. Our data demonstrate that a fine-tuned balance between RNApol2 pausing and elongation is crucial for normal neuronal development and suggest transcription pause-release as a druggable target for neurological defects in developmental disorders.